SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Xencor (XNCR)
XNCR 14.34-0.2%2:15 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (16)6/7/2014 9:44:49 AM
From: fitzdad55  Read Replies (1) of 136
 
Also P2 for ALL results possibly by end of 2014.

Thanks for highlighting this part of the presentation on MOR208. Sounds very promising.

On a more short term note, I wonder if the rise in XNCR's pps this week is connected to this update from Morphosys as well as Bassil's Thursday presentation at Jeffries where he highlighted three "value drivers" for this year: (1) XmAb5871 (with Amgen) P2a topline data; (2) XmAb7195 P1a--IGE reduction data; (3) IND enabling studies of a bispecific monoclonal antibody program in an oncology indication.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News